612 related articles for article (PubMed ID: 15763752)
1. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
Brunette MF; Mueser KT; Drake RE
Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
[TBL] [Abstract][Full Text] [Related]
2. Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care.
McNeese-Smith D; Nyamathi A; Longshore D; Wickman M; Robertson S; Obert J; McCann M; Wells K; Wenzel SL
Am J Drug Alcohol Abuse; 2007; 33(3):439-46. PubMed ID: 17613971
[TBL] [Abstract][Full Text] [Related]
3. Client retention in residential drug treatment for Latinos.
Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
[TBL] [Abstract][Full Text] [Related]
4. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
Choi S; Adams SM; MacMaster SA; Seiters J
J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
[TBL] [Abstract][Full Text] [Related]
5. Behavioral interventions for dual-diagnosis patients.
Goldsmith RJ; Garlapati V
Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
Brunette MF; Mueser KT
J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
[TBL] [Abstract][Full Text] [Related]
7. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
Matthews H; Kelly PJ; Deane FP
Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
[TBL] [Abstract][Full Text] [Related]
8. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
[TBL] [Abstract][Full Text] [Related]
10. Mental illness and substance use: an Australian perspective.
Munro I; Edward KL
Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
[TBL] [Abstract][Full Text] [Related]
11. The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems.
Kay-Lambkin FJ; Baker AL; Lewin TJ
Drug Alcohol Rev; 2004 Dec; 23(4):407-23. PubMed ID: 15763746
[TBL] [Abstract][Full Text] [Related]
12. Mental health and medical problems and service use among adolescent substance users.
Jaycox LH; Morral AR; Juvonen J
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):701-9. PubMed ID: 12921478
[TBL] [Abstract][Full Text] [Related]
13. Residential treatment: linkage with community drug treatment programs.
Meyers C; Moss I
Child Welfare; 1992; 71(6):537-45. PubMed ID: 1330451
[TBL] [Abstract][Full Text] [Related]
14. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
Cleary M; Hunt GE; Matheson S; Walter G
Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
[TBL] [Abstract][Full Text] [Related]
15. Predictors of engagement in continuing care following residential substance use disorder treatment.
Harris AH; McKellar JD; Moos RH; Schaefer JA; Cronkite RC
Drug Alcohol Depend; 2006 Sep; 84(1):93-101. PubMed ID: 16417977
[TBL] [Abstract][Full Text] [Related]
16. Responding to the threat of HIV among persons with mental illness and substance abuse.
Parry CD; Blank MB; Pithey AL
Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
[TBL] [Abstract][Full Text] [Related]
17. [Personality disorders and substance abuse disorders. Psychosocial strategies].
Lana Moliner F
Actas Esp Psiquiatr; 2001; 29(1):58-66. PubMed ID: 11333520
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Horsfall J; Cleary M; Hunt GE; Walter G
Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
[TBL] [Abstract][Full Text] [Related]
19. Programme factors that influence completion of residential treatment.
Meier PS; Best D
Drug Alcohol Rev; 2006 Jul; 25(4):349-55. PubMed ID: 16854661
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
